Somaxon Pharmaceuticals, Inc. today announced that Somaxon and Procter & Gamble have entered into a co-promotion agreement for Silenor (doxepin), a newly-approved treatment for insomnia characterized by difficulty with sleep maintenance.

Indiana University experts discuss the misuse of prescription drugs by college students and athletes; fitting exercise into a busy school schedule; returning to college to get a job; and insights into successful school referendum campaigns.

Johnson & Johnson today announced sales of $15.3 billion for the second quarter of 2010, an increase of 0.6% as compared to the second quarter of 2009. Operational results increased 0.1% and the positive impact of currency was 0.5%. � Domestic sales declined 2.8%, while international sales increased 4.1%, reflecting operational growth of 3.0% and a positive currency impact of 1.1%.

9 Jul 2010 - United States - Intellectual Property - IP Update - June 2010 - Part 1 - McDermott Will & Emery - In a much-anticipated ruling, the U.S. Court of Appeals for the Federal Circuit unanimously upheld the award of summary judgment to defendant-appellee Solo Cup, holding that plaintiff-appellant Matthew Pequignot raised no issue of material fact as to Solo Cup's lacking the requisite ...

J&J Starts Disclosing Drug Unit's Payments To Doctors